Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes.

[1]  Gregory D. Gromowski,et al.  Impact of prior dengue virus infection on Zika virus infection during pregnancy in marmosets , 2023, Science Translational Medicine.

[2]  M. Scaglione,et al.  Congenital Zika Syndrome: Genetic Avenues for Diagnosis and Therapy, Possible Management and Long-Term Outcomes , 2022, Journal of clinical medicine.

[3]  N. Michael,et al.  Neurocognitive impact of Zika virus infection in adult rhesus macaques , 2022, Journal of neuroinflammation.

[4]  S. Tardif,et al.  Efficacy of an inactivated Zika vaccine against virus infection during pregnancy in mice and marmosets , 2022, NPJ vaccines.

[5]  Y. Tong,et al.  A single nonsynonymous mutation on ZIKV E protein-coding sequences leads to markedly increased neurovirulence in vivo , 2022, Virologica Sinica.

[6]  C. Huang,et al.  The Specificity of the Persistent IgM Neutralizing Antibody Response in Zika Virus Infections among Individuals with Prior Dengue Virus Exposure , 2021, Journal of clinical microbiology.

[7]  T. Ying,et al.  Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy , 2021, Antibody therapeutics.

[8]  P. Brasil,et al.  Cohort profile: Study on Zika virus infection in Brazil (ZIKABRA study) , 2021, PloS one.

[9]  E. Davidson,et al.  A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies , 2020, Journal of Virology.

[10]  Weam I Zaky,et al.  Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor , 2020, Nature Medicine.

[11]  A. Brault,et al.  Zika Virus Shedding in Semen of Symptomatic Infected Men , 2018, The New England journal of medicine.

[12]  A. Sivasubramanian,et al.  Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation , 2018, Immunity.

[13]  T. Pierson,et al.  The Zika virus envelope protein glycan loop regulates virion antigenicity. , 2018, Virology.

[14]  P. Formenty,et al.  Study on the persistence of Zika virus (ZIKV) in body fluids of patients with ZIKV infection in Brazil , 2018, BMC Infectious Diseases.

[15]  K. Stiasny,et al.  The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design , 2017, EMBO reports.

[16]  M. Halloran,et al.  Antibody-dependent enhancement of severe dengue disease in humans , 2017, Science.

[17]  Bryan Briney,et al.  Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors , 2017, Science Immunology.

[18]  G. Gao,et al.  Monoclonal Antibodies against Zika Virus: Therapeutics and Their Implications for Vaccine Design , 2017, Journal of Virology.

[19]  Gregory D. Gromowski,et al.  Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques , 2017, PLoS pathogens.

[20]  Jian Wang,et al.  Delineating antibody recognition against Zika virus during natural infection. , 2017, JCI insight.

[21]  C. Rice,et al.  Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico , 2017, Cell.

[22]  R. Baric,et al.  Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection , 2017, Emerging infectious diseases.

[23]  Cinque S. Soto,et al.  Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation. , 2017, Cell reports.

[24]  A. García-Sastre,et al.  Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity , 2017, Science.

[25]  Andrew S. Miller,et al.  A human antibody against Zika virus crosslinks the E protein to prevent infection , 2017, Nature Communications.

[26]  Stephen J. Thomas,et al.  Prospects for a Zika Virus Vaccine , 2017, Immunity.

[27]  Lu Lu,et al.  Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III , 2017, Emerging microbes & infections.

[28]  G. B. Karlsson Hedestam,et al.  Production of individualized V gene databases reveals high levels of immunoglobulin genetic diversity , 2016, Nature Communications.

[29]  G. Gao,et al.  Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus , 2016, Science Translational Medicine.

[30]  R. Baric,et al.  Neutralization mechanism of a highly potent antibody against Zika virus , 2016, Nature Communications.

[31]  James E. Crowe,et al.  Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice , 2016, Nature.

[32]  M. Beltramello,et al.  Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection , 2016, Science.

[33]  J. Mascola,et al.  Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype. , 2016, Cell reports.

[34]  Anavaj Sakuntabhai,et al.  Structural basis of potent Zika–dengue virus antibody cross-neutralization , 2016, Nature.

[35]  Cinque S. Soto,et al.  Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses , 2016, Cell.

[36]  Jaime Prilusky,et al.  Automated Structure- and Sequence-Based Design of Proteins for High Bacterial Expression and Stability , 2016, Molecular cell.

[37]  Duncan R. Smith,et al.  Zika virus: history of a newly emerging arbovirus. , 2016, The Lancet. Infectious diseases.

[38]  Richard G. Jarman,et al.  Vaccine Protection Against Zika Virus from Brazil , 2016, Nature.

[39]  J. Wrammert,et al.  Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus , 2016, Proceedings of the National Academy of Sciences.

[40]  G. Screaton,et al.  Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus , 2016, Nature Immunology.

[41]  Carlos G Schrago,et al.  Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. , 2016, The Lancet. Infectious diseases.

[42]  Dennis R Burton,et al.  Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design. , 2016, Annual review of immunology.

[43]  Amadou A. Sall,et al.  The Brazilian Zika virus strain causes birth defects in experimental models , 2016, Nature.

[44]  M. Sapiano,et al.  Survey of Blood Collection Centers and Implementation of Guidance for Prevention of Transfusion-Transmitted Zika Virus Infection--Puerto Rico, 2016. , 2016, MMWR. Morbidity and mortality weekly report.

[45]  Emmanuel Fournier,et al.  Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study , 2016, The Lancet.

[46]  J. Mascola,et al.  Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability , 2016, PLoS pathogens.

[47]  T. Pierson,et al.  The 3.8 Å resolution cryo-EM structure of Zika virus , 2016, Science.

[48]  C. Cherry,et al.  Travel-Associated Zika Virus Disease Cases Among U.S. Residents--United States, January 2015-February 2016. , 2016, MMWR. Morbidity and mortality weekly report.

[49]  M. Diamond,et al.  Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere , 2016, Journal of Virology.

[50]  Pierre Brugières,et al.  Zika Virus Associated with Meningoencephalitis. , 2016, The New England journal of medicine.

[51]  C. E. J. Ayres.  Identification of Zika virus vectors and implications for control. , 2016, The Lancet. Infectious diseases.

[52]  Carlos Henrique Alencar,et al.  Zika virus outbreak in Brazil. , 2016, Journal of infection in developing countries.

[53]  Marko Kolenc,et al.  Zika Virus Associated with Microcephaly. , 2016, The New England journal of medicine.

[54]  Nicholas Jackson,et al.  Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. , 2015, The New England journal of medicine.

[55]  J. Mascola,et al.  Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection , 2015, Journal of Virology.

[56]  Xue-jun Fan,et al.  Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells , 2015, mAbs.

[57]  D. Musso,et al.  Potential Sexual Transmission of Zika Virus , 2015, Emerging infectious diseases.

[58]  Cameron P Simmons,et al.  A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus , 2014, Nature Immunology.

[59]  P. Desprès,et al.  Recognition determinants of broadly neutralizing human antibodies against dengue viruses , 2015, Nature.

[60]  G. Carrasquilla,et al.  Efficacy of a tetravalent dengue vaccine in children in Latin America. , 2015, The New England journal of medicine.

[61]  E. Davidson,et al.  A high‐throughput shotgun mutagenesis approach to mapping B‐cell antibody epitopes , 2014, Immunology.

[62]  Young Do Kwon,et al.  Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. , 2013, Immunity.

[63]  Ning Ma,et al.  IgBLAST: an immunoglobulin variable domain sequence analysis tool , 2013, Nucleic Acids Res..

[64]  K. Katoh,et al.  MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.

[65]  C. Sundling,et al.  Isolation of antibody V(D)J sequences from single cell sorted rhesus macaque B cells. , 2012, Journal of immunological methods.

[66]  C. Bailey-Kellogg,et al.  High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples. , 2012, Journal of immunological methods.

[67]  Baoshan Zhang,et al.  Broad and potent neutralization of HIV-1 by a gp41-specific human antibody , 2012, Nature.

[68]  T. Pierson,et al.  Degrees of maturity: the complex structure and biology of flaviviruses. , 2012, Current opinion in virology.

[69]  Ya-jun Guo,et al.  A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein , 2011, PloS one.

[70]  Mario Roederer,et al.  Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.

[71]  Vincent B. Chen,et al.  MolProbity: all-atom structure validation for macromolecular crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.

[72]  Vicki C. Ashley,et al.  Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia , 2008, Journal of Virology.

[73]  Martin Phillips,et al.  Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[74]  M. Rossmann,et al.  Cryo-EM Reconstruction of Dengue Virus in Complex with the Carbohydrate Recognition Domain of DC-SIGN , 2006, Cell.

[75]  S. Henikoff,et al.  Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[76]  M. K. Gentry,et al.  Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. , 1982, The American journal of tropical medicine and hygiene.

[77]  F. Macnamara.  Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. , 1954, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[78]  G. Dick,et al.  Zika virus. I. Isolations and serological specificity. , 1952, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[79]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[80]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .